42 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
recommendations in renal ... hypoglycaemic agents #Diabetes ... #Diabetic #Medications ... #Pharmacology # ... Dosing #Dosing #Renal
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... #pharmacology #pharmacotherapy ... #endocrinology ... #treatment
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... (Steglatro) #diabetes ... cardiovascular #renal ... SGLT2i #Inhibitors #pharmacology
TACROLIMUS - Side Effects Mnemonic

Tremor 
Alopecia 
Cardiovascular (HTN) 
Renal insufficiency 
Oncologic (Skin Cancer) 
Lipids (hyperlipidemia) 
Insulin
Cardiovascular (HTN) Renal ... Insulin dependent diabetes ... Seizures #Pharmacology
Causes of Hypermagnesemia
Increased magnesium load
 - Magnesium-containing laxatives, antacids, or enemas
 - Treatment of pre-edampsia/eclampsia (mothers
or enemas - Treatment ... neonates) - Diabetic ... Rhabdomyolysis Increased renal ... Mineralocorticoid deficiency, adrenal
Metformin 
Current Renal Dose Adjustments due to Risk of Lactic Acidosis 
> 60 No adjustment 
45-60
Metformin Current Renal ... #Metformin #Renal ... #Dosing #Dose #Pharmacology ... #Diabetes
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... adults with type 2 diabetes ... #Diabetes #Management ... #Algorithm #endocrinology ... #pharmacology #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... insulin in Type 1 Diabetes ... insulin dose for renal ... #Medications #pharmacology ... comparison #table #endocrinology
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... of renal bone disease ... the first-line treatments ... #Pharmacology #Pathophysiology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Inhibitors - Normal and Renal ... patients have renal ... DPP4 #Inhibitors #Renal ... #Dosing #Pharmacology ... #DM2 #Endocrinology